Okairos initiated a midstage trial of a gene-based preventive vaccine against hepatitis C using NIH funding. While most vaccines prompt an antibody response, Okairos' vaccine is designed to stimulate T cells, which help the body combat disease.
Preventive hepatitis C vaccine goes to midstage trial
SmartBrief Job Listings for Health Care
|Manager of Provider Network Analytics||
Geisinger Health System
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.